Status
Conditions
Treatments
About
The goal of this observational study is to to develop a noninvasive disease assessment system by leveraging artificial intelligence (AI) to comprehensively analyze multi-modal imaging features, including magnetic resonance enterography (MRE) and computed tomography enterography (CTE), for the diagnosis and prognostication of digestive diseases.
Participants will be randomly assigned to either conventional endoscopy or virtual endoscopy groups. The predictive performance of both groups for prognostic indicators, such as clinical remission rate and recurrence risk, will be compared during follow-up to verify the non-inferiority of the virtual endoscopy group.
Enrollment
Sex
Volunteers
Inclusion criteria
Patients with multimodal-confirmed diagnoses (clinical, imaging, endoscopic, and pathological) of:
Availability of ≥1 technically adequate CT or MR scan with high-quality colonoscopy performed within ±1 month of imaging.
Exclusion criteria
・Suboptimal imaging quality (e.g., low-dose artifacts, metal artifacts)
5,000 participants in 2 patient groups
Loading...
Central trial contact
Xuehua Li; Yaoqi Ke
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal